In vivo, the protective effect of PPARgamma overexpression on tumor progression has been tested in a rat NSCLC xenograft model [73], however, in this study, PPARgamma overexpression was seen not to be sufficient to inhibit NSCLC migration, while here exposure to the full DM treatment was seen to significantly reduce cell migration, pointing to a broader effect of the full medium. The gene discussed is PPARG; the disease is non-small cell lung carcinoma.